These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

58 related items for PubMed ID: 1819002

  • 1. A pharmacodynamic study of the renin inhibitor SR 43,845, administered intratracheally in conscious cynomolgus monkeys.
    Lacour C, Roccon A, Cazaubon C, Richaud JP, Segondy D, Nisato D.
    J Hypertens Suppl; 1991 Dec; 9(6):S384-5. PubMed ID: 1819002
    [No Abstract] [Full Text] [Related]

  • 2. Effect of an orally active renin inhibitor Cl-992 on blood pressure in normotensive and hypertensive monkeys.
    Ryan MJ, Hicks GW, Batley BL, Rapundalo ST, Patt WC, Taylor DG, Keiser JA.
    J Pharmacol Exp Ther; 1994 Jan; 268(1):372-9. PubMed ID: 8301578
    [Abstract] [Full Text] [Related]

  • 3. Cardiovascular actions of the primate-selective renin inhibitor, A-62198.
    Kleinert HD, Martin D, Chekal M, Young G, Rosenberg S, Plattner JJ, Perun TJ.
    J Pharmacol Exp Ther; 1988 Sep; 246(3):975-9. PubMed ID: 3047366
    [Abstract] [Full Text] [Related]

  • 4. Effects of a renin inhibitor, SR 43845, and of captopril on blood pressure and plasma active renin in conscious sodium-replete macaca.
    Lacour C, Cazaubon C, Roccon A, Segondy D, Wagnon J, Nisato D.
    J Hypertens Suppl; 1989 Apr; 7(2):S33-5. PubMed ID: 2666612
    [Abstract] [Full Text] [Related]

  • 5. Renal hemodynamic and excretory responses to renin inhibition induced by A-64662.
    Verburg KM, Kleinert HD, Chekal MA, Kadam JR, Young GA.
    J Pharmacol Exp Ther; 1990 Feb; 252(2):449-55. PubMed ID: 2179529
    [Abstract] [Full Text] [Related]

  • 6. An orally active renin inhibitor: cyclohexylnorstatine-containing dipeptide (KRI-1314).
    Miyazaki M, Etoh Y, Iizuka K, Toda N.
    J Hypertens Suppl; 1989 Apr; 7(2):S25-7. PubMed ID: 2666609
    [Abstract] [Full Text] [Related]

  • 7. Disparity between blood pressure and PRA inhibition after administration of a renin inhibitor to anesthetized dogs: methodological considerations.
    Palmer RK, Rapundalo ST, Batley BL, Barnes AE, Singh S, Ryan MJ, Taylor DG.
    Clin Exp Hypertens; 1993 Jul; 15(4):663-81. PubMed ID: 8374609
    [Abstract] [Full Text] [Related]

  • 8. Pharmacokinetics and pharmacodynamics of CI-992 following intravenous and oral administration to cynomolgus monkeys.
    Cook JA, Burger PJ, Michniewicz BM, Nordblom GD, Hicks GW, Kaplan C, Ryan MJ.
    Biopharm Drug Dispos; 1998 Apr; 19(3):185-91. PubMed ID: 9570002
    [Abstract] [Full Text] [Related]

  • 9. KRI-1314: an orally effective inhibitor of human renin.
    Etoh Y, Miyazaki M, Saitoh H, Toda N.
    Jpn J Pharmacol; 1993 Sep; 63(1):109-19. PubMed ID: 8271523
    [Abstract] [Full Text] [Related]

  • 10. Pharmacological properties of YM-21095, a potent and highly specific renin inhibitor.
    Shibasaki M, Asano M, Fukunaga Y, Usui T, Ichihara M, Murakami Y, Nakano K, Fujikura T.
    Am J Hypertens; 1991 Dec; 4(12 Pt 1):932-8. PubMed ID: 1815649
    [Abstract] [Full Text] [Related]

  • 11. Intraocular pressure lowering effects of the renin inhibitor ABBOTT-64662 diacetate in animals.
    Giardina WJ, Kleinert HD, Ebert DM, Wismer CT, Chekal MA, Stein HH.
    J Ocul Pharmacol; 1990 Dec; 6(2):75-83. PubMed ID: 2203852
    [Abstract] [Full Text] [Related]

  • 12. Effects of the renin inhibitor A-64662 in monkeys and rats with varying baseline plasma renin activity.
    Kleinert HD, Martin D, Chekal MA, Kadam J, Luly JR, Plattner JJ, Perun TJ, Luther RR.
    Hypertension; 1988 Jun; 11(6 Pt 2):613-9. PubMed ID: 3292414
    [Abstract] [Full Text] [Related]

  • 13. Acute hypotensive responses to peptide inhibitors of renin in conscious monkeys: an effect on blood pressure independent of plasma renin inhibition.
    Schaffer LW, Schorn TW, Winquist RJ, Strouse JF, Payne L, Chakravarty PK, de Laszlo SE, tenBroeke J, Veber DF, Greenlee WJ.
    J Hypertens; 1990 Mar; 8(3):251-9. PubMed ID: 2159506
    [Abstract] [Full Text] [Related]

  • 14. Pharmacology of novel imidazole alcohol inhibitors of primate renin.
    DeForrest JM, Waldron TL, Oehl RS, Scalese RJ, Free CA, Weller HN, Ryono DE.
    J Hypertens Suppl; 1989 Apr; 7(2):S15-9. PubMed ID: 2666607
    [Abstract] [Full Text] [Related]

  • 15. Acute effects of a pseudo-tetrapeptide as renin inhibitor on blood pressure and renin-angiotensin system of sodium-repleted and sodium-depleted hypertensive patients.
    Denolle T, Luo P, Guyene TT, Cazaubon C, Sissmann J, Corvol P, Ménard J.
    Arzneimittelforschung; 1993 Feb; 43(2A):255-9. PubMed ID: 8498973
    [Abstract] [Full Text] [Related]

  • 16. Hormonal and cardiovascular effects of losartan (DuP753), an angiotensin receptor antagonist, in nonhuman primates.
    DeGraaf GL, Pals DT, Couch SJ, Lawson JA.
    J Pharmacol Exp Ther; 1993 Jan; 264(1):6-10. PubMed ID: 8423551
    [Abstract] [Full Text] [Related]

  • 17. Human renin inhibiting dipeptide.
    Toda N, Miyazaki M, Etoh Y, Kubota T, Iizuka K.
    Eur J Pharmacol; 1986 Oct 07; 129(3):393-6. PubMed ID: 3536533
    [Abstract] [Full Text] [Related]

  • 18. Influence of elevated renin substrate on angiotensin II and arterial blood pressure in conscious mice.
    Cholewa BC, Mattson DL.
    Exp Physiol; 2005 Jul 07; 90(4):607-12. PubMed ID: 15833753
    [Abstract] [Full Text] [Related]

  • 19. Renin inhibitors containing new P1-P1' dipeptide mimetics with heterocycles in P1'.
    Raddatz P, Jonczyk A, Minck KO, Rippmann F, Schittenhelm C, Schmitges CJ.
    J Med Chem; 1992 Sep 18; 35(19):3525-36. PubMed ID: 1404233
    [Abstract] [Full Text] [Related]

  • 20. Haemodynamic effects of the renin inhibitor SR 42128 in conscious baboons.
    de Claviere M, Fourment P, Richaud JP, Unkovic J, Gagnol JP, Mazue G.
    J Hypertens Suppl; 1985 Dec 18; 3(3):S271-3. PubMed ID: 2856716
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 3.